Capricorn Fund Managers
RVMD icon

Capricorn Fund Managers’s Revolution Medicines RVMD Stock Holding History

Capricorn Fund Managers’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.05M Buy
+10,000
New +$1.98M 0.19% 101

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

Capricorn Fund Managers's RVMD Position: Q3 2026 in Review

Capricorn Fund Managers opened a new position in Revolution Medicines (RVMD) in Q3 2026: 10,000 shares worth $2.05M. The stake represents 0.19% of the portfolio and ranks #101 among its holdings.

577 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Capricorn Fund Managers held 10,000 shares of Revolution Medicines worth $2.05M as of Q3 2026.
  • Revolution Medicines was a new Capricorn Fund Managers position in Q3 2026.
  • Revolution Medicines made up 0.19% of Capricorn Fund Managers's portfolio in Q3 2026, its #101 holding.
  • 577 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Capricorn Fund Managers's 13F filing for Q3 2026, filed 3 Nov 2026.